SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-138010
Filing Date
2011-05-13
Accepted
2011-05-12 20:48:35
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 397271
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9564
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9751
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3927
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4279
  Complete submission text file 0001193125-11-138010.txt   425913
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 11837514
SIC: 2834 Pharmaceutical Preparations